Menu
ncarol.com
  • Home
  • Business
  • Financial
  • Yacht Buyer
  • Stocks
  • Finance
  • Banking
  • Nyse
  • Loans
ncarol.com

Elixia Announces New Hire Sam Searcy as Chief Commercial Officer
ncarol.com/10213312

Trending...
  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies
  • Still Using Ice? FrostSkin Reinvents Hydration
  • Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
Elixia
Sam Searcy joins Elixia, a site management organization, to oversee and increase business growth.

RESEARCH TRIANGLE PARK, N.C. - ncarol.com -- Elixia proudly welcomes Sam Searcy as the company's Chief Commercial Officer. Searcy will oversee activities related to marketing, enhance service offerings, expand Elixia's national site network, maintain client customer service, strategize Elixia's business growth, and increase Elixia's overall market share. Searcy will also manage Elixia's RTP office and the N.C.-based operations team.

"I am thrilled to have the opportunity to work with such a talented team. Elixia is truly implementing a breakthrough approach to clinical trials" Sam Searcy, CCO Searcy joins Elixia as an influential business and community leader with over 10 years of executive leadership roles in small and medium-sized companies in the life science sector. Searcy has a proven track record of building strong, efficient, and productive executive teams, and launching industry-disrupting products and services. Searcy also focuses on community as he serves on a number of corporate and volunteer Boards, including the N.C. Community College System, Appalachian State University Board of Visitors and ICE Global Consulting. He also serves as a Senior Advisor to NeuroVice, a Triangle-based medical device company focused on the medical needs of patients with various seizure disorders.

More on ncarol.com
  • Revolutionary Data Solution Transforms Health Insurance Underwriting Accuracy
  • $36 Million LOI to Acquire High Value Assets from Vivakor Inc in Oklahoma's STACK Play — Building Cash Flow and Scalable Power Infrastructure; $OLOX
  • Kobie Wins for AI Innovations in the 2026 Stevie® Awards for Sales & Customer Service
  • Berman | Sobin | Gross LLP Celebrates 35 Years of Advocating for Maryland's Injured Workers and Families
  • Art of Whiskey Hosts 3rd Annual San Francisco Tasting Experience During Super Bowl Week

"We are excited to have Sam join the Elixia team. Sam's years of experience in life sciences will help Elixia navigate our current period of rapid growth." Neal Patel, CEO. The addition of Searcy will add value to the Elixia team, accelerate the company's goals, and support Elixia's overall mission.

About Elixia

Elixia is a tech-enabled clinical site organization specializing in Cardiology, Nephrology, Behavioral Health, and Infectious disease trials. Elixia's mission: To provide pharmaceutical companies with a breakthrough approach to clinical trials while empowering physician research, reinventing access to diverse populations, and accelerating the collection of data vital to high-quality clinical research outcomes while comprehensively supporting the drug development process. Elixia maintains corporate headquarters in Palm Beach FL, and the Research Triangle Park.

Contact
Melinda Jackson Public Relations
***@melindajacksonpr.com


Source: Elixia

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Wespor Business Launches AI Voice and Chat Agents to Help Triangle Small Businesses Capture Missed Leads
  • America's Boating Club Ushers in New Board at Change of Watch
  • FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
  • $2.7 Million 2025 Revenue; All Time Record Sales Growth; 6 Profitable Quarters for Homebuilding Industry: Innovative Designs (Stock Symbol: IVDN)
  • CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety
  • PRÝNCESS Builds Anticipation With "My Nerves" — A Girls-Girl Anthem
  • Arbutus Medical Raises C$9.3M to Accelerate Growth of Surgical Workflow Solutions Outside the OR
  • From Sleepless Nights to Sold-Out Drops: Catch Phrase Poet's First Year Redefining Motivational Urban Apparel
  • Cold. Clean. Anywhere. Meet FrostSkin
  • How Specialized Game Development Services Are Powering the Next Wave of Interactive Entertainment
  • Don't Settle for a Lawyer Who Just Speaks Spanish. Demand One Who Understands Your Story
  • Dan Williams Promoted to Century Fasteners Corp. – General Manager, Operations
  • Ski Johnson Inks Strategic Deals with Three Major Food Chain Brands
  • NIL Club Advances Agent-Free NIL Model as Oversight Intensifies Across College Athletics
  • Atlanta Magazine Names Dr. Rashad Richey One of Atlanta's Most Influential Leaders in 2026 as the FIFA World Cup Approaches
  • Apostle Margelee Hylton Announces the Release of Third Day Prayer
  • Slotozilla Reports Strong Q4 Growth and Sigma Rome Success
  • "Lights Off" and Laughs On: Joseph Neibich Twists Horror Tropes in Hilariously Demonic Fashion
  • Families Gain Clarity: Postmortem Pathology Expands Private Autopsy Services in St. Louis
  • Beethoven: Music of Revolution and Triumph - Eroica
_catLbl0 _catLbl1

Popular on ncarol.com

  • Crossroads4Hope Welcomes New Trustees to Board of Directors as Organization Enters 25th Year of Caring - 119
  • Desert Mountain Club Earns Prestigious Blue Zones Approved™ Triple Designation, a New Standard for Well-Being in a Luxury Lifestyle Community
  • $80 Million Revenue Backlog for AI Cybersecurity Company Building the Future of Integrated Cybersecurity and Public Safety: $CYCU
  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies
  • Impact Futures Group expands through acquisition of specialist healthcare sector training provider Caring for Care
  • New Medium Article Explores Why Emotional Conversations Fail and What Most People Don't Understand About Connection
  • Does EMDR Really Work? New Article Explores How Trauma Gets Stuck in the Brain and How Healing Begins
  • Postmortem Pathology Expands to Phoenix: Bringing Families Answers During Their Most Difficult Moments
  • UK Financial Ltd Advances Compliance Strategy With January 30th CATEX Exchange Listing Of Maya Preferred PRA Preferred Class Regulated Security Token
  • Blasting Off with Space Sector Companies: Artemis II Manned Moon Mission is Set to Launch: Could $ASTI be on the Same Rocket Ride as $ASTS & $LUNR?

Similar on ncarol.com

  • Kobie Wins for AI Innovations in the 2026 Stevie® Awards for Sales & Customer Service
  • Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
  • Wespor Business Launches AI Voice and Chat Agents to Help Triangle Small Businesses Capture Missed Leads
  • FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
  • CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety
  • Arbutus Medical Raises C$9.3M to Accelerate Growth of Surgical Workflow Solutions Outside the OR
  • How Specialized Game Development Services Are Powering the Next Wave of Interactive Entertainment
  • Dan Williams Promoted to Century Fasteners Corp. – General Manager, Operations
  • NIL Club Advances Agent-Free NIL Model as Oversight Intensifies Across College Athletics
  • Families Gain Clarity: Postmortem Pathology Expands Private Autopsy Services in St. Louis
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute